Time Is Ticking: Secure Your Rights in the Sarepta Therapeutics Litigation
Investors who acquired shares or other securities in Sarepta Therapeutics, Inc. over the last two years are being reminded of a critical August 25, 2025 deadline to step forward in a proposed securities class action. The case, which alleges that the company misled the market, could offer a path to recover significant losses without any […]
Continue Reading